Dose Finding Study of Albuterol Sulfate in Patients With Intermittent or Persistent Mild Asthma
Status:
Withdrawn
Trial end date:
2015-10-01
Target enrollment:
Participant gender:
Summary
The drug product albuterol sulfate DPI, TBS-7, is a single dose inhalation product of
albuterol sulfate containing 240 ug albuterol sulphate (200 ug of albuterol) and inhalation
grade lactose in a new dry powder delivery system called the Trivair deposition system.
Three different doses of albuterol sulfate DPI, TBS-7, will be administered in this dose
ranging clinical trial: an optimal dose, 80% of the optimal dose and 50% of the optimal dose
and will be compared with placebo and an active comparator.